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Background: Systemic inflammation is pivotal in the pathogenesis of cardiovascular disease. 
Since inflammation can directly cause cardiomyocyte injury, we hypothesized that 
established systemic inflammation, as reflected by elevated preoperative neutrophil-
lymphocyte ratio (NLR) >4 (a threshold predictive of cardiovascular morbidity/mortality) 
predisposes patients to perioperative myocardial injury. 
Methods: We prospectively recruited 1652 patients aged ≥45 years who underwent non-
cardiac surgery in two UK centres. Serum high sensitivity troponin T concentrations (hsTnT) 
were measured on the first three post-operative days.  Clinicians and investigators were 
blinded to the troponin results. The primary outcome was perioperative myocardial injury, 
defined as hsTnT ≥14ng.L-1 within three days after surgery. We assessed whether myocardial 
injury was associated with preoperative NLR>4 and/or activated ROS generation in 
circulating monocytes. Multivariable logistic regression analysis explored associations 
between age, gender, NLR, Revised Cardiac Risk Index (RCRI), individual leukocyte subsets 
(monocytes, eosinophils) and myocardial injury. Flow cytometric quantification of ROS in 
activated circulating monocytes was correlated with NLR (n=21 patients). Data are presented 
as n (%) or odds ratios (OR:95% confidence intervals). 
Results: Preoperative NLR>4 was present in 239/1652 (14.5%) patients. Myocardial injury 
occurred in 405/1652 (24.5%) patients and was more common in patients with preoperative 
NLR>4 (OR:2.56 [1.92-3.41]; p<0.0001). Myocardial injury was independently associated 
with lower absolute preoperative lymphocyte count (OR:1.80 [1.50-2.17];p<0.0001) and 
higher absolute preoperative monocyte count (OR:1.93 [1.12-3.30];p=0.017). Monocyte ROS 
generation correlated with NLR (r=0.47; p=0.03). 
Conclusions: Preoperative NLR>4 is associated with perioperative myocardial injury, 










Asymptomatic myocardial injury occurs in more than 30% of patients undergoing non-
cardiac surgery, 1, 2 Even apparently minor elevations in troponin are associated with 
prolonged hospitalisation and higher mortality. The extent and severity of coronary artery 
disease, however, does not correlate closely with the occurrence of perioperative myocardial 
injury.3 Furthermore, pharmacological interventions that are effective in acute coronary 
syndromes do not prevent myocardial infarction after surgery,4-6 although longer-term 
adverse cardiac outcomes may be improved by  intensification of medical management for 
acute coronary syndrome.7, 8 These data suggest that pathophysiological mechanisms other 
than ischaemia and/or thrombosis may contribute to perioperative myocardial injury.   
Systemic inflammation plays a major role in the development of cardiovascular 
disease.9-11 Inhibition of interleukin (IL)-1β, a cytokine that is pivotal to pro-inflammatory 
pathways, reduces cardiovascular events in patients with established cardiac disease.12 
Mediators of systemic inflammation directly injure cardiomyocytes13 and/or modulate their 
response to damage.14, 15 The systemic inflammatory response is an important contributor to 
myocardial injury, and to damage of other organs, after myocardial infarction and cardiac 
surgery. The extent to which systemic inflammation is involved in the pathogenesis of 
myocardial injury after non-cardiac surgery is not known. 
The neutrophil-lymphocyte ratio (NLR) is a readily available and inexpensive marker 
of systemic inflammation driven by elevated levels of circulating cytokines which have been 
shown to modulate myocardial injury.16, 17 NLR enhances the Framingham-based risk 
prediction of cardiovascular mortality,18 with higher NLR associated with adverse outcomes 
after acute coronary syndromes19 and decompensated heart failure.20 NLR is also associated 




Other leukocyte subsets, including higher monocyte counts,22 and lower eosinophil counts,23 
may also contribute to the development of cardiovascular morbidity. 
Here, we hypothesized that the development of perioperative myocardial injury may 
be modified by mechanisms invoked by systemic inflammation. We assessed prospectively 
whether systemic inflammation, as reflected by elevated preoperative NLR and/or leukocyte 
subsets implicated in the pathogenesis of cardiomyocyte dysfunction, may promote 
perioperative myocardial injury. As a further test of this hypothesis, we assessed whether 
circulating monocytes, which are pivotal for the repair of myocardial injury, generated more 




We report the results of a prospectively designed sub-study from two UK centres which 
captured leukocyte data where investigators, patients and healthcare providers were blinded to 
troponin results throughout the study period. The study was approved by UK NRES Committee 
London (MREC:10/WNo03/25). It was conducted in accordance with the principles of the 
declaration of Helsinki and institutional guidelines. Participants undergoing elective 
noncardiac surgery gave written informed consent before surgery.  
 
Participants 
Participants were aged 45 years or older and underwent non-cardiac surgery under general or 
regional anaesthesia at The Royal London Hospital (Barts Health NHS Trust) or at University 
College Hospital (University College London Hospitals NHS Foundation Trust) who 
required at least one night in hospital after surgery. Participants were excluded if they refused 







Researchers collected a detailed and standardised dataset from patients and their medical 
records, before and during the 30 days after surgery, including postoperative morbidity 
(defined by PostOperative Morbidity Survey and Clavien-Dindo grading). Full definitions of 
the variables included in this analysis are documented in the supplementary file. Blood 
samples were taken before, between 6-12 hours after the end of surgery, and on postoperative 
days one, two and three.  
 
Exposures 
Leukocyte subsets were measured preoperatively by observers masked to troponin results 
(Sysmex XE2100 analyzer, Sysmex, Milton Keynes, UK). NLR >4 was defined 
prospectively as an established median threshold value associated with subclinical 
inflammation and adverse clinical outcomes derived from studies totalling 40,559 patients.24 
Moreover, a population-based study reported mean NLR 1.76 (95% confidence intervals: 
0.83–3.92) in >8500 participants.25  We assessed the contributions of specific leukocyte 
subsets to perioperative myocardial injury using absolute counts and thresholds associated 
with cardiovascular risk in the general cardiovascular literature. Lymphopaenia was defined 
as <1x109 lymphocytes.L-1. 26 The following thresholds for absolute subset counts were used: 









The primary outcome measure was perioperative myocardial injury defined as serum high 
sensitivity troponin T concentration ([hs TnT]) ≥14ng.L-1, measured by high sensitivity 
troponin T assay (Elecsys, Roche, Basel, Switzerland) within three days after surgery. This 
hsTnT assay enables the detection of cTnT at the 99th percentile of an apparently healthy 
reference population with <10% variability, with a 5ng/L limit of detection.27  We did not 
seek to define ischaemic versus non-ischaemic causes of hsTnT elevation, since elevated 
troponin is linked to poorer clinical outcomes regardless of its aetiology.28 The secondary 
clinical outcome was length of hospital stay, stratified by NLR</>4 and/or hs-TnT ≥14ng.L-1. 
 
Preoperative monocyte reactive oxygen species generation 
Preoperative monocyte reactive oxygen species (ROS) generation was measured by flow 
cytometry in a subset of 21 patients. Investigators undertaking flow cytometry were masked 
to NLR values. Monocytes were identified by forward/side scatter characteristics and CD14+ 
CD16- surface staining (Supplementary Figure 1). Using fresh whole blood samples obtained 
preoperatively, loaded with dihydrorhodamine (DHR)-123 (10μm), monocyte ROS were 
quantified after dimethyl sulfoxide (control) or phorbol 12-myristate 13-acetate (PMA) 
incubation for 10 minutes at 37°C in a CO2 incubator (Phagoburst, Orpegen, Heidelberg, 
Germany).29 The ROS-reactive dye DHR is converted to cationic green fluorescent 
rhodamine-123 upon oxidation by PMA, trapping it intracellularly. Median fluorescence 
intensity was quantified by flow cytometry (CyAn ADP flow cytometer, Beckman Coulter, 
Wycombe, UK). PMA-induced ROS was expressed as fold-change over each individual’s 







The statistical analysis was prospectively planned and registered on a public database 
(Research Registry:3927). We used NCSS 11 (Utah, USA) and STATA version 14 
(StataCorp LP, Texas, USA) to analyse the data. We ordered the sample according to integer 
values of NLR</>4 and stratified the baseline characteristics of the cohort according to this 
threshold. Binary data were expressed as percentages, normally distributed continuous data as 
mean with standard deviation (SD), and non-normally distributed continuous data as median 
with interquartile range (IQR). We used multivariable logistic regression analysis to test for 
associations between leukocyte subsets (absolute counts) and perioperative myocardial 
injury, taking into account established conventional risk factors (age, gender, and the Revised 
Cardiac Risk Index (RCRI),).30-33 The selection of covariates was based on prior evidence of 
association with the dependent variable or similar clinical outcomes, rather than using 
univariable analysis or p-value based approaches.34, 35 Covariates were treated as categorical 
variables. Missing data were handled by list-wise deletion. Fold-change in monocyte ROS 
(stimulation/basal ROS levels) was correlated with NLR using simple linear regression. 
 
Sample size estimation 
Our previous work in four UK centres showed that preoperative NLR>4 is present in 
approximately 20% of patients undergoing noncardiac surgery.36 Observations from the main 
VISION study, suggest that ~25% of patients develop hsTnT ≥14ng.L-1 within 72h after 
surgery.1 We therefore estimated that at least 1554 patients would be required to detect a 10% 
absolute difference in incidence of hsTnT ≥14ng.L-1 within 72h after surgery between 
patients with and without preoperative NLR>4 (α=0.05; 1-β=0.9; estimated dropout rate of 
~7%). For the monocyte ROS experiment, we estimated a total sample size ≥19 subjects 





The study included 1682 patients, who were recruited between March 2011 and May 2014.  
(Figure 1). Preoperative NLR >4 was present in 239 (14.2%) patients (Supplementary Figure 
2). A RCRI score >2 was more common in 52/239 (21.8%) patients with NLR>4 (odds ratio: 
2.36 (95% CI: 1.66-3.36); p<0.001), but age, gender and other perioperative and preoperative 
cardiovascular parameters were similar (table 1). Measures of frailty, cardiovascular 
medication or surgical subspecialty were similar as stratified by NLR>4 (Supplementary 
figures 3-5). 
 
Primary outcome: myocardial injury and neutrophil-lymphocyte ratio 
Perioperative myocardial injury was sustained in 405/1652 (24.5%) patients. Signs and/or 
symptoms of myocardial ischaemia were reported in 2/405 (0.49%) patients. Median troponin 
rise was 18 (14-26) ng.L-1 in patients with troponin ≥14ng.L-1 within 72h after surgery. No 
patients required coronary angiography during the same hospital stay.  Perioperative 
myocardial injury was more frequent in 99/239 (41.4%) patients with preoperative NLR>4, 
compared to 306/1413 (21.7%) patients with NLR ratio <=4 (odds ratio:2.56 [95%CI:1.92-
3.41]; p<0.0001). Adjusting for RCRI, age and gender, NLR was independently associated 
with perioperative myocardial injury either when dichotomised by NLR</>4 (odds ratio:2.27 
(95%CI:1.67-3.09); p<0.001) or considered as a continuous variable (odds ratio:1.06 
(95%CI:1.02-1.10); p<0.001); Supplementary Tables 1-3). The combination of high 
preoperative NLR and myocardial injury was associated with prolonged length of stay 
(hazard ratio:1.45 (95%CI:1.17-1.80); p<0.001; Figure 2). This relationship was similar 





Leukocyte subsets and myocardial injury 
Using thresholds described in the wider cardiovascular literature, we found that myocardial 
injury was more frequent among 45/105 (42.6%) patients with preoperative lymphopaenia, 
compared to 345/1549 (22.3%) patients with a lymphocyte count >1x109 cells.L-1 (odds 
ratio:2.62 (95%CI:1.75-3.92); p<0.0001). Similarly, a higher proportion of patients with an 
absolute neutrophil count >6x109cells.L-1 (88/294; 29.9%) sustained myocardial injury (odds 
ratio:1.5 (95%CI:1.14-1.99); p<0.0001). For monocytes, myocardial injury was more 
frequent in 129/440 (29.3%) patients with a monocyte count ≥0.7x109cells.L-1, 22 
compared to 261/1213 (21.5%) patients with a monocyte count <0.7x109cells.L-1 (odds 
ratio:1.51 (95%CI:1.18-1.94); p<0.0001). No relationship was found between previously 
described thresholds for eosinophil count (<0.05 cells.109L-1) and myocardial injury (odds 
ratio:0.99 (95%CI: 0.69-1.43); p=0.55). 
Multivariable logistic regression analysis of leukocyte subsets and myocardial injury. 
Adjusting for RCRI, age and gender (Table 2), elevated postoperative troponin was 
independently associated with lower preoperative absolute lymphocyte count (odds ratio:1.80 
[95%CI:1.50-2.17]; p<0.0001) and higher preoperative absolute monocyte count (odds 
ratio:1.93 [1.12-3.30]; p=0.017).  
Monocyte ROS generation in relation to preoperative NLR  
Clinical characteristics for these patients are shown in Supplementary Table 4. Higher 
preoperative NLR was significantly associated with more ROS release from activated 






The principal finding of this prospective observational cohort study involving more than 
1600 elective patients undergoing noncardiac surgery showed that elevated preoperative 
NLR, which reflects established systemic inflammation, was associated with increased risk of 
myocardial injury as measured by a high-sensitivity, cardiac-specific troponin assay. Our data 
implicate specific leukocyte subsets, suggesting that relative lymphopaenia and higher levels 
of circulating monocytes may play a mechanistic role in the development of perioperative 
myocardial injury. Monocytes, when obtained from patients with higher NLR, generate more 
injurious ROS when activated ex vivo. Taken together, these data suggest that a common, 
readily attainable leukocyte-based biomarker indicates that dysregulated inflammation may 
contribute to perioperative troponin rises.  
These data reflect the findings of several studies exploring NLR in the cardiovascular 
literature, although these have primarily focussed on longer term outcomes rather than short-
term risk of cardiac injury.37 Our data provide further mechanistic insight, since preoperative 
NLR appears to be associated with a potentially more injurious monocyte phenotype. Murine 
models of myocardial infarction show that monocytes produced in the bone marrow and 
spleen are recruited to the injured myocardium in two distinct phases.38 Within 24 hours after 
myocardial infarction, angiotensin II mediates the release of monocytes from the spleen.  The 
first phase involves B lymphocyte coordinated recruitment of monocytes; depletion of B cells 
reduces monocyte infiltration and infarct size.39 At least in mice, this first phase is 
characterised by Ly-6chigh monocytes which give rise to inflammatory macrophages that clear 
damaged tissue by phagocytosis and secretion of proteolytic enzymes. This is followed by the 
infiltration of Ly-6clow macrophages that promote wound healing, angiogenesis and 




of PMI that are capable of releasing more injurious ROS may contribute to more extensive 
myocardial tissue damage. 
By contrast, relative higher lymphocyte counts were associated with less myocardial 
injury. These findings are consistent with previous prospective work we have undertaken 
showing that lymphopaenia is associated with excess cardiovascular morbidity after elective 
orthopaedic surgery.26 Genetic deficiency, or depletion of CD4+ T-cells impairs wound 
healing in murine models of myocardial infarction.40 CD4+ T-cells modulate monocyte 
infiltration; their absence increases left ventricular dilatation and mortality after murine 
myocardial infarction.41 We have previously shown that lymphopaenia in perioperative 
patients is characterised by lower T and B cell populations,26 so the relationship between 
protective T cell and deleterious B cell phenotypes requires further elucidation. However, 
reduced NLR is also associated with poor cardiorespiratory reserve,36 which may also 
contribute to perioperative myocardial injury.42  
A strength of our large, prospective, generalizable study is the blinded measurement 
of high sensitivity troponin, an objective biomarker linked to adverse outcome.1 The 
exploration of widely available leukocyte measurements adds further generalisability.  Since 
causality cannot be inferred from observational data, we are unable to discount that 
intraoperative management and drug therapy may play an important role in mitigating or 
exacerbating the influence of chronically elevated systemic inflammation. While the aim of 
this study was to identify a broadly defined inflammatory phenotype linked to myocardial 
injury, a further limitation is the lack of additional, integrative functional immune data. 
Although numbers of circulating leukocytes may correlate with function, they do not 
necessarily reflect their phenotype at sites of tissue injury. We cannot discount that frailty 




correlated with higher NLR.43  Similarly, other unmeasured confounders may influence these 
data. Further investigations are required to establish how a number of inflammatory 
mechanisms reflected by higher NLR may be involved in perioperative myocardial injury. 
We have previously shown that non-classical monocyte subsets, which produce the highest 
levels of inflammatory cytokines in response to toll-like receptor ligands,44 are more 
prevalent in patients with higher perioperative risk.45 Upregulation of endothelial adhesion 
molecules, chemokines and/or cytokines may promote arrhythmias.46 Excess inflammation 
may destabilize atherosclerotic plaques47  or exacerbate microvascular pathophysiology.48  
In summary, these data provide support for an alternative hypothesis that may, in part, 
explain the high incidence of perioperative myocardial injury being related to chronically 
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Figure 2. Length of hospital stay in relation to troponin events and 
neutrophil:lymphocyte ratio.  
Kaplan-Meier plot showing time to hospital discharge, stratified by patients preoperative 
NLR and/or development of raised troponin. Numbers at risk for each category are matched 






Figure 3. Neutrophil:lymphocyte ratio and monocyte reactive oxygen species 
generation.  
A. Histograms showing monocyte intracellular reactive oxygen species before (grey) 
and after (red) whole blood samples obtained preoperatively from 21 patients were 
stimulated with PMA. 
Monocyte responses are 
shown from patients 
with high and low 
preoperative NLR. For 
clarity, unstained 
samples are not shown.  
B. Correlation between 
preoperative NLR and 
fold-change (over basal 
values) in monocyte 







Table 1. Patient characteristics.  
Descriptive data stratified by neutrophil-lymphocyte ratio </>4, presented as numbers with 
percentages (%) or means with standard deviations (SD). Age is rounded to nearest whole 
number. Neutrophil-lymphocyte ratio (NLR). Estimated glomerular filtration rate (eGFR). * 
Preoperative CRP available in 241 patients.  
 
Characteristic NLR>4 NLR<4  P  
Number of patients 239 1413  
Age (years) 65 (12) 67 (12) 0.03 
Female gender (n;%) 98 (41.0%) 715 (50.6%) 0.005 
Body Mass Index (SD) 30 (7) 28 (7) 0.02 
Systolic blood pressure (mmHg) 138 (21) 135 (21) 0.09 
Diastolic blood pressure (mmHg) 75 (12) 73 (13) 0.004 
Heart rate (beats.min-1) 76 (13) 77 (13) 0.36 
RCRI ≥2 (n; %) 52 (21.8%) 185 (13.1%) <0.001 
Estimated GFR (ml.min-1) 81 (21) 79 (33) 0.23 
Haemoglobin (g L-1) 123 (21) 134 (16) <0.001 
White cell count (cells.109 L-1) 9.6 (4.3) 7.1 (2.1) <0.001 
Neutrophil count (cells.109 L-1) 7.5 (3.9) 4.2 (1.5) <0.001 
Lymphocyte count (cells.109 L-1) 1.2 (0.5) 2.1 (0.8) <0.001 
Monocyte count (cells.109 L-1) 0.68 (0.34) 0.56 (0.23) <0.001 
Basophil count (cells.109 L-1) 0.02 (0.03) 0.04 (0.1) <0.001 
Eosinophil count (cells.109 L-1) 0.14 (0.15) 0.2 (0.19) <0.001 
Platelets (cells.109 L-1) 275 (118) 255 (75) 0.004 
C reactive protein* (mg.L-1) 16 (4-72) 3 (1-14) <0.001 
Albumin (g.dL-1) 41 (6) 45 (4) <0.001 
Moderate or high risk surgery (n; 
%) 
214 (89.5%) 1289 (91.2%)  
Hepatobiliary 7 (2.9%) 75 (5.3%)  
Gastrointestinal 31 (13.0%) 241 (17.1%)  
Vascular  22 (9.2%) 59 (4.2%)  
Urology 38 (15.9%) 246 (17.4%)  
Neurosurgery 16 (6.7%) 85 (6.0%)  
Gynaecological 20 (8.4%) 129 (9.1%)  
Head/neck/ear, nose, 
throat 
12 (5.0%) 54 (3.8%)  
Orthopaedic 71 (29.7%) 440 (31.1%)   
Duration of surgery (minutes) 135 (96-204) 130 (90-195) 0.47 
Allogenic blood products (n;%) 14 (5.8%) 53 (3.8%) 0.15 
Postoperative critical care 
admission    
Level 2 (n;%) 39 (16.3%) 239 (16.9%) 0.52 




Table 2. Multivariable logistic regression model of leukocyte subsets associated with 
myocardial injury after non-cardiac surgery.  
Dependent variable is myocardial injury within first three days of surgery. Lower absolute 
lymphocyte, and higher absolute monocyte counts, were independently associated with 
myocardial injury. Absolute leukocyte subset counts were treated as continuous variables. 
Results presented as odds ratios with 95% confidence intervals.  
 
 
Odds ratio (95% CI) P value 
Age  1.03 (1.02-1.04) <0.0001 
Male gender 1.08 (0.84-1.38) 0.553 
RCRI (compared to zero score)  
 
1 1.64 (1.27-2.12) <0.0001 
2 3.55 (2.28-5.53) <0.0001 
≥3 6.29 (2.47-16.05) <0.0001 
Neutrophils 1.04 (0.98-1.10) 0.202 
Lymphocytes 0.56 (0.46-0.67) <0.0001 
Monocytes 1.93 (1.12-3.30) 0.017 
Eosinophils 1.58 (0.70-3.58) 0.274 
Basophils 3.81 (0.13-109.80) 0.436 
 
